Times Square Capital Management, LLC Blueprint Medicines Corp Transaction History

Times Square Capital Management, LLC

$6.49 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$45.23 - $70.15 $11 Million - $17.1 Million	-243,899 Closed	0 $0
Q1 2022 May 06, 2022	SELL	$54.1 - $110.08 $61.9 Million - $126 Million	-1,143,431 Reduced 82.42%	243,899 $15.6 Million
Q4 2021 Feb 04, 2022	SELL	$94.25 - $115.99 $7.65 Million - $9.42 Million	-81,215 Reduced 5.53%	1,387,330 $149 Million
Q3 2021 Nov 08, 2021	SELL	$80.98 - $109.47 $8.63 Million - $11.7 Million	-106,550 Reduced 6.76%	1,468,545 $151 Million
Q2 2021 Aug 09, 2021	BUY	$82.78 - $101.0 $12.1 Million - $14.7 Million	146,025 Added 10.22%	1,575,095 $139 Million
Q1 2021 May 12, 2021	BUY	$90.71 - $108.28 $16.7 Million - $19.9 Million	183,665 Added 14.75%	1,429,070 $139 Million
Q4 2020 Feb 12, 2021	BUY	$92.08 - $124.48 $13.4 Million - $18.1 Million	145,270 Added 13.2%	1,245,405 $140 Million
Q3 2020 Nov 06, 2020	BUY	$66.45 - $92.7 $22 Million - $30.7 Million	331,285 Added 43.09%	1,100,135 $102 Million
Q2 2020 Aug 07, 2020	BUY	$57.09 - $79.27 $131,592 - $182,717	2,305 Added 0.3%	768,850 $60 Million
Q1 2020 May 08, 2020	SELL	$48.11 - $82.22 $9.18 Million - $15.7 Million	-190,885 Reduced 19.94%	766,545 $44.8 Million
Q4 2019 Feb 05, 2020	BUY	$66.73 - $82.59 $7.18 Million - $8.89 Million	107,610 Added 12.66%	957,430 $76.7 Million
Q3 2019 Nov 05, 2019	BUY	$72.9 - $101.41 $3.63 Million - $5.05 Million	49,800 Added 6.22%	849,820 $62.4 Million
Q2 2019 Aug 02, 2019	SELL	$73.54 - $97.8 $4.02 Million - $5.34 Million	-54,600 Reduced 6.39%	800,020 $75.5 Million
Q1 2019 May 10, 2019	SELL	$48.7 - $86.6 $7.16 Million - $12.7 Million	-147,020 Reduced 14.68%	854,620 $68.4 Million
Q4 2018 Feb 14, 2019	SELL	$45.57 - $74.26 $1.8 Million - $2.93 Million	-39,400 Reduced 3.78%	1,001,640 $54 Million
Q3 2018 Nov 14, 2018	SELL	$58.91 - $78.32 $1.76 Million - $2.34 Million	-29,900 Reduced 2.79%	1,041,040 $0
Q2 2018 Aug 14, 2018	BUY	$60.96 - $101.18 $14.3 Million - $23.7 Million	234,565 Added 28.05%	1,070,940 $68 Million
Q1 2018 May 15, 2018	SELL	$73.28 - $102.95 $19.7 Million - $27.7 Million	-268,855 Reduced 24.33%	836,375 $76.7 Million
Q4 2017 Feb 14, 2018	BUY	$62.91 - $88.32 $14.9 Million - $21 Million	237,530 Added 27.37%	1,105,230 $83.3 Million
Q3 2017 Nov 09, 2017	BUY	$42.37 - $69.67 $13 Million - $21.4 Million	307,700 Added 54.95%	867,700 $60.5 Million
Q2 2017 Aug 10, 2017	BUY	N/A	560,000	560,000 $28.4 Million

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

Vanguard Group Inc Valley Forge, PA

6.68M
Shares

$605 Million
0.01% of portfolio
Black Rock Inc. New York, NY

6.65M
Shares

$601 Million
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

5.39M
Shares

$487 Million
0.06% of portfolio
Wellington Management Group LLP Boston, MA

3.96M
Shares

$359 Million
0.07% of portfolio
State Street Corp Boston, MA

2.77M
Shares

$250 Million
0.01% of portfolio

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Times Square Capital Management, LLC with notifications on news.

Account